Class action is a newish feature within South Africa's legal landscape. Cases such as the silicosis matter are likely to influence many more.
Professor Samir Brahmachari's innovative Open Source Drug Development allows thousands of researchers to work together to discover novel therapies for under-studied diseases.
There's a growing body of evidence that shows we could be doing more for the close to billion children at risk of intestinal worms. We simply cannot afford to ignore it.
South African scientists have found a way to single out the problematic parts of the bacteria causing TB that results in drug resistance.
There is an increasing focus on alternative treatment strategies, developed to treat other diseases and conditions but re-purposed to tackle TB.
As much as animals may pass on viruses to humans, humans pass on viruses which are sometimes lethal to the animal world as well.
More than 1.5 million people die of tuberculosis across the world every year. Although testing and screening has improved and more drugs are available, it is not enough to conquer the scourge.